Which B2B Technologies Are Beneficial, and Which Are Vaporware? with Josh Lupresto of Telarus

Technology is like fashion; it can be really cyclical. Today’s trends can be tomorrow’s faux pas, and some things are created for function, while others are just for show. With so many choices available, where do business owners turn to when purchasing the technology that’s going to enhance or run the core of their business?

Today’s guest on the Software & Technology Podcast is Josh Lupresto, vice president of sales engineering for Telarus, a technology services distributor. Being the “brokers” in the B2B technology world, interacting with OEMs to provide products to sub-agent vendors, Telarus has the unique position of keeping their ear to the ground, knowing what technology is trending even before it happens in a time where cutting through the technological fluff is forever difficult.

Lupresto explains how some technologies have become expected staples, like MPLS, and others have shown unexpected usefulness. The evolution of SD-LAN is also creating a game-changing environment for the customer, because no longer do they have to log in to each of their devices to make a change; they can set easy routing rules and application priorities across multiple devices, countries, routers, etc.

At the end of the day, the operation is what pays the mortgage, and “we always run the risk of making the wrong tech recommendation or being scrutinized, especially with the new perspectives in the AI and IoT realm, so we’d better make sure that if we’re going to bring a product to the market, we better do a good job of vetting it before we put our rubber stamp on it,” Lupresto said.

Listen to Lupresto break down the struggles of communicating what’s useful and what’s “vaporware,” how Telarus acts like gate-keepers giving honest feedback to tech companies, and where are we right now with business-focused technological solutions and how it mirrors an era of growth or struggle we’ve already seen.

For the latest news, videos, and podcasts in the Software & Electronics Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!
Twitter – @TechMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More